Manufacturer of energy-based therapeutic devices with a worldwide exclusive license, catering to both individuals (B2C) and healthcare facilities (B2B). Our products help people manage chronic stress, which is known to exacerbate symptoms of many conditions, including pain, inflammation, energy levels, digestion, and sleep disorders.

Our flagship products, the Magnesphere and Halo, use Magnetic Resonance Therapy (MRT) with extremely low-level, natural magnetic fields to stimulate the Vagus nerve, thereby promoting nervous system balance.

Our FDA-authorized claim states that our devices “enhance feelings of relaxation.”

Recurring Revenue & SaaS Business Model

A major strength of our business is our recurring revenue model, which is powered by a Software as a Service (SaaS) platform that enables ongoing subscription-based access to our technology. This SaaS-based system provides treatment protocols, device connectivity, and remote management capabilities, ensuring a seamless experience for both commercial and home users.

Our devices are sold for both commercial and residential use, with the SaaS platform serving as a primary revenue driver:
• Healthcare providers (clinicians & wellness centers) pay $12–$15 per hour per session to access treatment protocols through the SaaS platform.
• Home users pay a monthly subscription of $80–$130, allowing them to receive continuous access to therapy sessions via the connected system.
• Our Halo device lease program (at $299/month), developed during COVID-19, has been highly successful and further strengthens our SaaS-based revenue stream.

For 2024, approximately 85% of our revenue is recurring, generated through:
* SaaS subscriptions
* Device leases
* Financing payments

This high-margin, recurring revenue model creates a predictable cash flow and offers significant scalability. A new owner with expertise in SaaS, digital health, or wellness technology could further expand the platform, introduce AI-driven treatment recommendations, or integrate with existing telehealth ecosystems.

Exclusive Worldwide License & Intellectual Property

We hold an exclusive worldwide license to use this technology for wellness applications with the claim of “enhancing feelings of relaxation.” This license includes a substantial patent portfolio and intellectual property assets.

As part of the sale, a 3% license fee (royalty) is paid quarterly on all sales related to this technology.

Key FAQs

1. How does the technology work?

Our technology is based on research from the University of Oklahoma’s Heart Rhythm Institute. Studies indicate that our low-level electromagnetic fields stimulate the Vagus Nerve, helping to balance the Autonomic Nervous System (ANS).
The ANS controls the body’s fight-or-flight (Sympathetic) and rest-and-digest (Parasympathetic) responses.

2. How does the SaaS model enhance the user experience?

Our SaaS platform is integral to the therapy experience, providing:
• Automated treatment session scheduling
• Remote system monitoring and software updates
• Customized therapy protocols based on user data
• AI-driven analytics to enhance relaxation outcomes (potential future expansion)

This digital-first approach allows us to offer a scalable, subscription-based model that improves engagement and retention for both commercial and home users.

Why This Business is an Exciting Opportunity

This business would be an excellent fit for a company already offering complementary wellness products such as infrared saunas, laser therapy, hyperbaric chambers, floatation tanks, cryotherapy, or salt rooms. Adding our technology to an existing wellness portfolio could expand market reach and increase revenue streams.

Additionally, a buyer with expertise in SaaS, telehealth, or digital wellness platforms could leverage our subscription model to drive further adoption and develop new revenue streams through data-driven wellness solutions.